Litcius/Paper detail

Risk of Serious Infection Associated with Agents that Target T-Cell Activation and Interleukin-17 and Interleukin-23 Cytokines

Stanford Shoor

2020Infectious Disease Clinics of North America13 citationsDOI

Topics & Concepts

MedicinePsoriasisRheumatoid arthritisPsoriatic arthritisImmunologyAnkylosing spondylitisInterleukin 17CytokineArthritisDiseaseInterleukin 15TuberculosisInterleukinSpondylitisInternal medicinePathologyPsoriasis: Treatment and PathogenesisAutoimmune and Inflammatory Disorders ResearchImmunodeficiency and Autoimmune Disorders
Risk of Serious Infection Associated with Agents that Target T-Cell Activation and Interleukin-17 and Interleukin-23 Cytokines | Litcius